La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

AREV Life Sciences Global Gestione

Gestione criteri di controllo 1/4

AREV Life Sciences Global's Il CEO è Mike Withrow, nominato in Oct2018, ha un mandato di 6.92 anni. possiede direttamente 43.44% delle azioni della società, per un valore di CA$ 1.24M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.8 anni e 2.5 anni.

Informazioni chiave

Mike Withrow

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	5yrs
Proprietà del CEO	43.4%
Durata media del management	3.8yrs
Durata media del Consiglio di amministrazione	2.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

How Much Are AREV NanoTec Brands Inc. (CSE:AREV) Insiders Taking Off The Table?

Jan 02

AMMINISTRATORE DELEGATO

Mike Withrow

5yrs

Mandato

Mr. Michael Withrow, also known as Mike, serves as Director at AREV Life Sciences Global Corp. (formerly known as AREV NanoTec Brands Inc.) (formerly known as AREV Brands International Ltd.) (formerly, ARE...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Michael Withrow	Chairman & CEO	5yrs	Nessun dato	43.44% CA$ 1.2m
Denby Greenslade	Interim CFO	3.8yrs	CA$72.00k	1.15% CA$ 33.0k
Donald Shaxon	Vice President of Marketing	2.8yrs	Nessun dato	Nessun dato

3.8yrs

Durata media

Gestione esperta: Il team dirigenziale di AREV è considerato esperto (durata media dell'incarico 3.8 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Michael Withrow	Chairman & CEO	6.9yrs	Nessun dato	43.44% CA$ 1.2m
Denby Greenslade	Interim CFO	3.8yrs	CA$72.00k	1.15% CA$ 33.0k
Kevin Phelps	Director	2.7yrs	CA$18.24k	Nessun dato
Harold Smith	Member of Scientific Advisory Board	2.3yrs	Nessun dato	Nessun dato
Roscoe Moore	Chairman of Scientific Advisory Board	2.7yrs	Nessun dato	Nessun dato
Douglas Sorocco	Member of Scientific Advisory Board	1.7yrs	Nessun dato	Nessun dato
Uma V. Dhanabalan	Member of Scientific Advisory Board	2.7yrs	Nessun dato	Nessun dato
Jay Noller	Member of Scientific Advisory Board	2.7yrs	Nessun dato	Nessun dato
Richard Van Breemen	Member of Scientific Advisory Board	2.3yrs	Nessun dato	Nessun dato
Allan Echino	Director	1.8yrs	Nessun dato	2.42% CA$ 69.1k
Brian Elliott	Director	1.6yrs	Nessun dato	Nessun dato
Sateesh Apte	Member of Scientific Advisory Board	1.2yrs	Nessun dato	Nessun dato

2.5yrs

Durata media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di AREV non è considerato esperto (durata media del mandato 2.5 anni), il che suggerisce un nuovo consiglio.

AREV Life Sciences Global Gestione

Gestione criteri di controllo 1/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

AREV Life Sciences Global Corp., Annual General Meeting, Apr 05, 2024

No independent directors

No independent directors

No independent directors

AREV Life Sciences Global Corp. Announces the Resignation of Melvin Maxwell from Board

No independent directors

Recent updates

AREV Life Sciences Global Corp., Annual General Meeting, Apr 05, 2024

No independent directors

No independent directors

No independent directors

AREV Life Sciences Global Corp. Announces the Resignation of Melvin Maxwell from Board

No independent directors

Third quarter 2022 earnings released: CA$0.008 loss per share (vs CA$0.009 loss in 3Q 2021)

Chairman & CEO recently bought CA$59k worth of stock

No independent directors

AREV Life Sciences Global Corp. Announces Management Changes

Second quarter 2022 earnings released: CA$0.026 loss per share (vs CA$0.028 loss in 2Q 2021)

AREV Life Sciences Global Corp. Announces the Appointment of Sateesh Apte to the Scientific Advisory Board

Full year 2021 earnings released: CA$0.051 loss per share (vs CA$0.068 loss in FY 2020)

No independent directors

AREV Life Sciences Global Corporation Appoints Brian V. Elliott to its Board of Directors

AREV Life Sciences Global Corp. Appoints Kevin Phelps as Chief Operating Officer

AREV Life Sciences Global Corp. Appoints Douglas Sorocco to Its Scientific Advisory Committee

AREV Life Sciences Settles Pending Litigation with Harvey

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

AREV Life Sciences Global Corp. (CNSX:AREV) acquired Wright and Well Essentials Inc. for CAD 0.02 million.

Chairman & CEO exercised options to buy CA$200k worth of stock.

Chairman & CEO recently sold CA$125k worth of stock

Second quarter 2021 earnings released: CA$0.028 loss per share (vs CA$0.017 loss in 2Q 2020)

First quarter 2021 earnings released: CA$0.026 loss per share (vs CA$0.012 loss in 1Q 2020)

AREV NanoTec Brands Inc. Expands Extraction Results to Clinical Characterization of Compounds, Development of Advanced-Stage Therapeutic Foods and Discovery of Plant-Based Drugs

AREV NanoTec Brands Inc. announced that it has received CAD 0.67 million in funding

Arev Nanotec Brands Inc. Appoints Chad S. Johnson, Esq. as Special Counsel for Corporate Development

AREV NanoTec Brands Inc. Announces Addition of Kevin J. Phelps to its Board of Directors

AREV NanoTec Brands Inc. Appoints Dr. Jay Noller to its Scientific Advisory Board

AREV’s Nanotech Initiates Early-Stage Antiviral Photochemistry Derivation Discovery Program for Pandemic Viral Pathogens

New 90-day high: CA$0.42

AREV Appoints Dr. Roscoe Moore to Join the Advisory Board

AREV NanoTec Brands Inc. Corporate Update on Latest Innovation

AREV NanoTec Brands Inc. Appoints Dr. Uma V. A. Dhanabalan as Advisory Board

AREV NanoTec Brands Inc. announced that it expects to receive CAD 0.725 million in funding

AREV NanoTec Brands Inc. announced that it has received CAD 0.1 million in funding from Chiron Partners LLC

How Much Are AREV NanoTec Brands Inc. (CSE:AREV) Insiders Taking Off The Table?

New 90-day high: CA$0.22

Chairman & CEO recently sold CA$261k worth of stock

AREV NanoTec Brands Inc. Receives Its First Trial Run of Its Naturvac Immune Boost

AREV NanoTec Brands Inc. Appoints Don Shaxon to the Position of VP Marketing

First half earnings released

AREV Brands International Ltd. (CNSX:AREV) cancelled the acquisition of 5,300 square foot facility and a 100 acre cannabis and hemp cultivation in California.

AREV NanoTec Brands Inc. announced that it expects to receive CAD 0.16 million in funding

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media

Membri del Consiglio di amministrazione

Durata media